- GNBT Stock Page
Generex Biotechnology Corp. (NASDAQ-CM:GNBT)
Last Update: 18 minutes ago
| Change: | -0.02 (-2.68%) |
| Last Trade: | 0.71 |
| Prev Close: | 0.73 |
| Share Volume: | 387,589 |
| Market Cap: | 79.69M |
| EPS (Earnings per share): | -0.28 |
| P/E (Price/earning ratio): | N/A |
| P/B (Price/book ratio): | 2.29 |
| Stock Price History | |
|---|---|
| Beta: | 0.46 |
| 52 week change: | -51.00% |
| 52 week high: | 1.95 |
| 52 week low: | 0.63 |
| 50 day moving avarage: | 0.77 |
| 200 day moving avarage: | 1.01 |
| Dividends | |
| Ex dividend date: | N/A |
| Dividend yield: | N/A |
| Dividend rate: | N/A |
| Share Statistics | |
| Avarage 10 day volume: | 378,667 |
| Shares outstanding: | 112,180,123 |
| Short interest date: | Jul 28, 2008 |
| Short shares: | 3,116,493 |
| Short ratio: | 9.00 |
| Short % of float: | 2.80% |
Thu, 28 Aug 2008 3:45 PM
After-Hours:
0.71
-0.00 (-0.01%)
| Today | 5d | 1m | 3m | 6m | 1y | 5y |
Latest Headlines for GNBT
Company Profile
Sector: Healthcare
Industry: Drugs
Engaged in the research drug delivery technology
The Company and its wholly-owned subsidiary is engaged in the research and development of drug delivery systems and technology.
GNBT Headlines
-
8 hours ago
Generex CEO Interview With Business News Network Available Online -
Aug 25 at 8:31 ET
Generex Biotechnology Signs Oral Insulin Distribution Deal for Korea -
Aug 21 at 9:30 ET
Generex Biotechnology Inks Glucose RapidSpray Distribution Deal in Brazil -
Aug 20 at 1:00 ET
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation -
Aug 12 at 10:11 ET
Generex Announces Enrollment of Over 150 Patients in Phase III Trial of Generex Oral-lyn -
Aug 08 at 9:35 ET
Generex Biotechnology Comments On Recent Trading Activity -
Aug 07 at 9:15 ET
Enrollment of Breast and Ovarian Cancer Patients Commenced for Combination Therapy Trial to Include Generex Biotechnology's Novel Immunotherapeutic Vaccine -
Aug 05 at 9:30 ET
Generex Biotechnology to Commence Generex Oral-lyn Trial Involving Subjects With Impaired Glucose Tolerance -
Jul 30 at 8:31 ET
Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC -
Jul 25 at 4:00 ET
Generex Biotechnology Granted Additional Time to Comply With NASDAQ Listing Requirement
Top members owning GNBT
-
Top 36%
-0.81%3m:
-0.81%YTD:
-
Top 2%
-10.37%3m:
3.76%YTD:
-
Top 1%
-18.15%3m:
145.04%YTD: